Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification

Abstract Computed tomography (CT) is a widely used imaging modality. Among the recent technical improvements to increase the range of detection for optimized diagnostic, new devices such as dual energy CT allow elemental discrimination but still remain limited to two energies. Spectral photon-counti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Niki Halttunen, Frederic Lerouge, Frederic Chaput, Marc Vandamme, Szilvia Karpati, Salim Si-Mohamed, Monica Sigovan, Loic Boussel, Emmanuel Chereul, Philippe Douek, Stephane Parola
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/106655db334f4c4eb3c375fe5b259c65
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:106655db334f4c4eb3c375fe5b259c65
record_format dspace
spelling oai:doaj.org-article:106655db334f4c4eb3c375fe5b259c652021-12-02T16:07:54ZHybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification10.1038/s41598-019-48641-z2045-2322https://doaj.org/article/106655db334f4c4eb3c375fe5b259c652019-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-48641-zhttps://doaj.org/toc/2045-2322Abstract Computed tomography (CT) is a widely used imaging modality. Among the recent technical improvements to increase the range of detection for optimized diagnostic, new devices such as dual energy CT allow elemental discrimination but still remain limited to two energies. Spectral photon-counting CT (SPCCT) is an emerging X-ray imaging technology with a completely new multiple energy detection and high spatial resolution (200 μm). This unique technique allows detection and quantification of a given element thanks to an element-specific increase in X-ray absorption for an energy (K-band) depending on its atomic number. The main contrast media used hitherto are iodine-based compounds but the K-edge of iodine (33.2 keV) is out of the range of detection. Therefore, it is crucial to develop contrast media suitable for this advanced technology. Gadolinium, well known and used element for MRI, possess a K-edge (50.2 keV) well suited for the SPCCT modality. The use of nano-objects instead of molecular entities is pushed by the necessity of high local concentration. In this work, nano-GdF3 is validated on a clinical based prototype, to be used as efficient in vivo contrast media. Beside an extremely high stability, it presents long lasting time in the blood pool allowing perfusion imaging of small animals, without apparent toxicity.Niki HalttunenFrederic LerougeFrederic ChaputMarc VandammeSzilvia KarpatiSalim Si-MohamedMonica SigovanLoic BousselEmmanuel ChereulPhilippe DouekStephane ParolaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Niki Halttunen
Frederic Lerouge
Frederic Chaput
Marc Vandamme
Szilvia Karpati
Salim Si-Mohamed
Monica Sigovan
Loic Boussel
Emmanuel Chereul
Philippe Douek
Stephane Parola
Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
description Abstract Computed tomography (CT) is a widely used imaging modality. Among the recent technical improvements to increase the range of detection for optimized diagnostic, new devices such as dual energy CT allow elemental discrimination but still remain limited to two energies. Spectral photon-counting CT (SPCCT) is an emerging X-ray imaging technology with a completely new multiple energy detection and high spatial resolution (200 μm). This unique technique allows detection and quantification of a given element thanks to an element-specific increase in X-ray absorption for an energy (K-band) depending on its atomic number. The main contrast media used hitherto are iodine-based compounds but the K-edge of iodine (33.2 keV) is out of the range of detection. Therefore, it is crucial to develop contrast media suitable for this advanced technology. Gadolinium, well known and used element for MRI, possess a K-edge (50.2 keV) well suited for the SPCCT modality. The use of nano-objects instead of molecular entities is pushed by the necessity of high local concentration. In this work, nano-GdF3 is validated on a clinical based prototype, to be used as efficient in vivo contrast media. Beside an extremely high stability, it presents long lasting time in the blood pool allowing perfusion imaging of small animals, without apparent toxicity.
format article
author Niki Halttunen
Frederic Lerouge
Frederic Chaput
Marc Vandamme
Szilvia Karpati
Salim Si-Mohamed
Monica Sigovan
Loic Boussel
Emmanuel Chereul
Philippe Douek
Stephane Parola
author_facet Niki Halttunen
Frederic Lerouge
Frederic Chaput
Marc Vandamme
Szilvia Karpati
Salim Si-Mohamed
Monica Sigovan
Loic Boussel
Emmanuel Chereul
Philippe Douek
Stephane Parola
author_sort Niki Halttunen
title Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
title_short Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
title_full Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
title_fullStr Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
title_full_unstemmed Hybrid Nano-GdF3 contrast media allows pre-clinical in vivo element-specific K-edge imaging and quantification
title_sort hybrid nano-gdf3 contrast media allows pre-clinical in vivo element-specific k-edge imaging and quantification
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/106655db334f4c4eb3c375fe5b259c65
work_keys_str_mv AT nikihalttunen hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT fredericlerouge hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT fredericchaput hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT marcvandamme hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT szilviakarpati hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT salimsimohamed hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT monicasigovan hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT loicboussel hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT emmanuelchereul hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT philippedouek hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
AT stephaneparola hybridnanogdf3contrastmediaallowspreclinicalinvivoelementspecifickedgeimagingandquantification
_version_ 1718384638654676992